Suppr超能文献

硬膜外介入治疗慢性脊柱疼痛管理:美国介入疼痛医师学会(ASIPP)综合循证指南。

Epidural Interventions in the Management of Chronic Spinal Pain: American Society of Interventional Pain Physicians (ASIPP) Comprehensive Evidence-Based Guidelines.

机构信息

Pain Management Centers of America, Paducah, KY and Evansville, IN; LSU Health Science Center, New Orleans, LA.

Vice Chair for Research and Education, Department of Anesthesiology and Pain Management, Advocate Illinois Masonic Medical Center, Clinical Associate Professor of Anesthesiology and Surgery at University of Illinois, Chicago, IL.

出版信息

Pain Physician. 2021 Jan;24(S1):S27-S208.

Abstract

BACKGROUND

Chronic spinal pain is the most prevalent chronic disease with employment of multiple modes of interventional techniques including epidural interventions. Multiple randomized controlled trials (RCTs), observational studies, systematic reviews, and guidelines have been published. The recent review of the utilization patterns and expenditures show that there has been a decline in utilization of epidural injections with decrease in inflation adjusted costs from 2009 to 2018. The American Society of Interventional Pain Physicians (ASIPP) published guidelines for interventional techniques in 2013, and guidelines for facet joint interventions in 2020. Consequently, these guidelines have been prepared to update previously existing guidelines.

OBJECTIVE

To provide evidence-based guidance in performing therapeutic epidural procedures, including caudal, interlaminar in lumbar, cervical, and thoracic spinal regions, transforaminal in lumbar spine, and percutaneous adhesiolysis in the lumbar spine.

METHODS

The methodology utilized included the development of objective and key questions with utilization of trustworthy standards. The literature pertaining to all aspects of epidural interventions was viewed with best evidence synthesis of available literature and  recommendations were provided.

RESULTS

In preparation of the guidelines, extensive literature review was performed. In addition to review of multiple manuscripts in reference to utilization, expenditures, anatomical and pathophysiological considerations, pharmacological and harmful effects of drugs and procedures, for evidence synthesis we have included 47 systematic reviews and 43 RCTs covering all epidural interventions to meet the objectives.The evidence recommendations are as follows: Disc herniation: Based on relevant, high-quality fluoroscopically guided epidural injections, with or without steroids, and results of previous systematic reviews, the evidence is Level I for caudal epidural injections, lumbar interlaminar epidural injections, lumbar transforaminal epidural injections, and cervical interlaminar epidural injections with strong recommendation for long-term effectiveness.The evidence for percutaneous adhesiolysis in managing disc herniation based on one high-quality, placebo-controlled RCT is Level II with moderate to strong recommendation for long-term improvement in patients nonresponsive to conservative management and fluoroscopically guided epidural injections. For thoracic disc herniation, based on one relevant, high-quality RCT of thoracic epidural with fluoroscopic guidance, with or without steroids, the evidence is Level II with moderate to strong recommendation for long-term effectiveness.Spinal stenosis: The evidence based on one high-quality RCT in each category the evidence is Level III to II for fluoroscopically guided caudal epidural injections with moderate to strong recommendation and Level II for fluoroscopically guided lumbar and cervical interlaminar epidural injections with moderate to strong recommendation for long-term effectiveness.The evidence for lumbar transforaminal epidural injections is Level IV to III with moderate recommendation with fluoroscopically guided lumbar transforaminal epidural injections for long-term improvement. The evidence for percutaneous adhesiolysis in lumbar stenosis based on relevant, moderate to high quality RCTs, observational studies, and systematic reviews is Level II with moderate to strong recommendation for long-term improvement after failure of conservative management and fluoroscopically guided epidural injections. Axial discogenic pain: The evidence for axial discogenic pain without facet joint pain or sacroiliac joint pain in the lumbar and cervical spine with fluoroscopically guided caudal, lumbar and cervical interlaminar epidural injections, based on one relevant high quality RCT in each category is Level II with moderate to strong recommendation for long-term improvement, with or without steroids. Post-surgery syndrome: The evidence for lumbar and cervical post-surgery syndrome based on one relevant, high-quality RCT with fluoroscopic guidance for caudal and cervical interlaminar epidural injections, with or without steroids, is Level II with moderate to strong recommendation for long-term improvement. For percutaneous adhesiolysis, based on multiple moderate to high-quality RCTs and systematic reviews, the evidence is Level I with strong recommendation for long-term improvement after failure of conservative management and fluoroscopically guided epidural injections.

LIMITATIONS

The limitations of these guidelines include a continued paucity of high-quality studies for some techniques and various conditions including spinal stenosis, post-surgery syndrome, and discogenic pain.

CONCLUSIONS

These epidural intervention guidelines including percutaneous adhesiolysis were prepared with a comprehensive review of the literature with methodologic quality assessment and determination of level of evidence with strength of recommendations.

摘要

背景

慢性脊柱疼痛是最常见的慢性疾病,采用多种介入技术模式,包括硬膜外介入。已经发表了多项随机对照试验(RCT)、观察性研究、系统评价和指南。最近对利用模式和支出的审查表明,硬膜外注射的利用率下降,2009 年至 2018 年经通胀调整后的成本下降。美国介入性疼痛医师学会(ASIPP)于 2013 年发布了介入技术指南,2020 年发布了关节突关节介入指南。因此,编写了这些指南以更新先前存在的指南。

目的

提供执行治疗性硬膜外手术的循证指导,包括腰骶部、颈胸段的骶管、腰椎间、颈椎间和胸椎间、腰椎经椎间孔和经皮粘连松解术。

方法

采用制定客观和关键问题的方法,并利用可靠的标准。对所有硬膜外介入方面的文献进行了回顾,对可用文献进行了最佳证据综合,并提出了建议。

结果

在准备指南时,进行了广泛的文献回顾。除了对与利用、支出、解剖和病理生理学考虑、药物和程序的药理和有害影响相关的多个手稿进行审查外,我们还包括了 47 项系统评价和 43 项 RCT,涵盖了所有硬膜外介入,以满足目标。证据推荐如下:椎间盘突出症:基于相关的、高质量的透视引导下硬膜外注射,包括或不包括类固醇,以及以前系统评价的结果,证据是 I 级,适用于骶管硬膜外注射、腰椎间硬膜外注射、腰椎经椎间孔硬膜外注射和颈椎间硬膜外注射,具有长期有效性的强烈推荐。基于一项高质量、安慰剂对照 RCT 的经皮粘连松解术治疗椎间盘突出症的证据为 II 级,对于对保守治疗和透视引导下硬膜外注射无反应的患者具有中度至强烈的长期改善推荐。对于胸椎间盘突出症,基于一项高质量的、透视引导下胸椎硬膜外注射的 RCT,包括或不包括类固醇,证据为 II 级,具有长期有效性的强烈推荐。椎管狭窄症:基于每一类的一项高质量 RCT 的证据,透视引导下骶管硬膜外注射的证据为 III 级至 II 级,具有中度至强烈的推荐,透视引导下腰椎和颈椎间硬膜外注射的证据为 II 级,具有中度至强烈的推荐用于长期有效性。腰椎经椎间孔硬膜外注射的证据为 IV 级至 III 级,具有中度推荐,用于透视引导下腰椎经椎间孔硬膜外注射的长期改善。基于相关的、中度至高质量 RCT、观察性研究和系统评价的经皮粘连松解术治疗腰椎狭窄症的证据为 II 级,具有中度至强烈的推荐,用于保守治疗和透视引导下硬膜外注射失败后的长期改善。轴向椎间盘源性疼痛:基于每一类的一项相关的、高质量的 RCT,在腰骶部和颈段,没有小关节疼痛或骶髂关节疼痛的情况下,透视引导下骶管、腰椎和颈椎间硬膜外注射的证据为 II 级,具有中度至强烈的推荐,用于长期改善,包括或不包括类固醇。手术后综合征:基于一项相关的、高质量的 RCT,对于透视引导下骶管和颈椎间硬膜外注射,包括或不包括类固醇,证据为 II 级,具有中度至强烈的推荐,用于长期改善。对于经皮粘连松解术,基于多项中度至高质量的 RCT 和系统评价,证据为 I 级,具有强烈的推荐,用于保守治疗和透视引导下硬膜外注射失败后的长期改善。

局限性

这些指南的局限性包括一些技术和各种情况,包括椎管狭窄症、手术后综合征和椎间盘源性疼痛,仍然缺乏高质量的研究。

结论

这些硬膜外介入指南包括经皮粘连松解术,是在对文献进行全面审查的基础上编写的,方法学质量评估和确定证据水平以及推荐强度。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验